Medical Data Vision Co., Ltd.
3902.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | ¥6 | ¥6 | ¥6 | ¥6 |
| % Growth | -8% | 5.2% | 7.6% | – |
| Cost of Goods Sold | ¥2 | ¥1 | ¥1 | ¥1 |
| Gross Profit | ¥4 | ¥5 | ¥5 | ¥5 |
| % Margin | 73.3% | 78.4% | 82.4% | 81.9% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥4 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥4 | ¥3 | ¥3 | ¥3 |
| Sales & Mktg Exp. | ¥1 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥4 | ¥3 | ¥3 | ¥3 |
| Operating Income | ¥0 | ¥2 | ¥2 | ¥2 |
| % Margin | 0.1% | 27.6% | 28.8% | 28.1% |
| Other Income/Exp. Net | -¥1 | -¥0 | -¥0 | -¥0 |
| Pre-Tax Income | -¥1 | ¥2 | ¥1 | ¥2 |
| Tax Expense | ¥0 | ¥1 | ¥1 | ¥0 |
| Net Income | -¥1 | ¥1 | ¥1 | ¥1 |
| % Margin | -13.4% | 15.3% | 14.3% | 19.2% |
| EPS | -20.73 | 25.63 | 22.77 | 27.74 |
| % Growth | -180.9% | 12.6% | -17.9% | – |
| EPS Diluted | -20.73 | 25.63 | 22.76 | 27.74 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥0 | ¥2 | ¥2 | ¥2 |
| % Margin | 2.2% | 29.2% | 31.3% | 30.5% |